Congress Needs to Know What Cannabis Scheduling Means for Patients

Now that federal health agencies have confirmed cannabis has accepted medical use in the United States, the conversation has changed. Now is the time to call on federal policymakers. They need to hear the perspectives of patient advocates. 

Cannabis therapeutics are helping millions of Americans, often where all traditional options have failed or as a safer treatment option. While state-level initiatives have demonstrated the potential of medical cannabis treatments, the lack of federal regulations poses challenges for patients, researchers, and medical practitioners, keeping cannabis treatments from reaching their full potential. Rescheduling alone will not change this. 

A national cannabis program would fill this void, ensuring uniformity of regulations, restoring the rights of medical cannabis patients, creating nationwide access for therapeutic use and research, and forging a new, purpose-built pathway for cannabis therapeutics.

Americans for Safe Access has developed a legislative framework for a national medical cannabis program that builds on the knowledge from the state-level experiment, includes input from patients, regulators, researchers, medical professionals, medical cannabis providers, and patient originations, and incorporates the experience of the 65 countries with federal medical cannabis programs. 

Send a letter to your federal representatives asking them to support medical cannabis patients by creating a national medical cannabis program.